Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Chronic traumatic encephalopathy rare among individuals with isolated brain injuries

Chronic traumatic encephalopathy (CTE) is more common in people who experience extensive repetitive head impacts, and infrequent among individuals with isolated brain injuries or less extensive impacts, researchers from the Brain Injury Research Center of Mount Sinai have found.

The study, published in the Journal of Neuropathology & Experimental Neurology, adds to knowledge of CTE, which has received extensive media attention amidst limited research in representative samples.

CTE is characterized by a neurodegenerative pathology involving abnormal accumulations of tau protein in the brain associated with head trauma, primarily identified in deceased people who sustained extensive exposure to repetitive head impacts while playing contact sports—especially American-style football. CTE has been reported more rarely in individuals who sustained repetitive head impacts through head-banging, military service, or intimate partner violence.

Psoriasis-linked gene mutation also impacts gut health, scientists discover

A mutation previously linked to skin disorders like psoriasis may also play a surprising role in gut health, according to new research published by scientists at VIB-UGent and colleagues from UGent, the University of Barcelona, and University College London. This mutation activates skin immune responses but also affects the intestine.

This finding, published in EMBO Molecular Medicine, reveals a new connection between genetics, the immune system, and the gut, which may have therapeutic implications.

Scientists under the leadership of Dr. Inna Afonina and Prof. Rudi Beyaert (VIB-UGent Center for Inflammation Research) have found that a mutation in the gene CARD14, known for activating skin immune responses in psoriasis patients, also affects the intestine. This mutation reduces gut motility, promotes mild inflammation, and increases vulnerability to bacterial infections.

Anti-CD19 CAR T-Cell Therapy in Advanced Stiff-Person Syndrome and Concomitant Myasthenia Gravis

The immune system works to identify and target invading pathogens. Specifically, our bodies work to get rid of any harmful infections by employing a two-part immune response. The first wave of immunity is the innate immune system. This initial reaction is broad and non-specific with innate cells circulating throughout the body to detect foreign pathogens. These cells that are involved include neutrophils, macrophages, eosinophils, basophils, and dendritic cells. Once cells detect an issue, they alert the rest of the body to completely filter out the infection. Importantly, the second wave of immunity, or the adaptive immune system, elicits a strong, specific response that target pathogens the innate immune system cannot neutralize.

Adaptive immunity builds to generate robust protection against aggressive diseases. The cells that make up this response include B and T cells. B cells are mainly responsible for generating antibodies to neutralize and signal infections throughout the body. T cells are the drivers that get rid of disease. T cell activity destroys infected cells and other pathogens lingering throughout the body or site of infection. The adaptive immune response is also critical for immune memory. Once someone experiences a disease and recovers, adaptive immune cells will remember that pathogen next time it enters the body — this is how vaccines work. A patient is injected with a non-harmful virus to expose the immune system. Immediately, the body will respond and destroy the virus. However, a few T cells will also be generated to targeted similar viruses in the future. As a result, when a patient is exposed to the infection again, they will be protected and not experience symptoms.

T cells are critical for any disease or infection, including cancer. Many immunotherapies currently being develop involve activating and directing T cells to the site of the tumor. However, immunotherapies have limited efficacy due to various mechanisms around the tumor that suppress immunity. Scientists are working to understand T cell biology to develop better immunotherapies and more accurately predict treatment outcomes in patients.

Fungal secrets of a sunken ship: Advanced decay found throughout USS Cairo despite past wood preservation efforts

University of Minnesota researchers studied the microbial degradation of the USS Cairo, one of the first ironclad and steam-powered gunboats used in the United States Civil War. Studies of microbial degradation of historic woods are essential to help protect and preserve important cultural artifacts.

Built in 1861, the ship hit a torpedo and sank in December 1862 and was recovered about 100 years later from the Yazoo River. It has been on display at the Vicksburg National Military Park in Mississippi. Although the ship has a canopy cover, it is exposed to environmental elements.

“Continued degradation of this historic Civil War ship is causing serious concerns for its long-term preservation. To determine the appropriate conservation efforts, it is essential to understand the current condition of the wood and the microorganisms causing the degradation,” said lead author Robert Blanchette, a professor in the College of Food, Agricultural and Natural Resource Sciences.

/* */